Evogene Statistics
NASDAQ: EVGNIndustrialsAgricultural ChemicalsUSD
0.3162+0.0032 (+1.02%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Evogene by the numbers
Evogene has a market capitalization of $5.7 million based on 18.05M shares outstanding. With trailing EPS of $-1.55, Evogene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.6% below its 50-day average and 48.3% below its 200-day average.
Average daily trading volume is 1.40M shares, or about $443,939 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EVGN valuation vs. peer median
| Metric | EVGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.71M | $9.09M | -37% |
| Avg. volume | 1.40M | 355.59K | +295% |
Peer median across 8 companies: SNES, FRTT, NXTS, BIOX, ICL, UAN, AVD, CBUS.
Valuation
- Market cap
- $5.71M
- Price / sales (latest FY)
- 1.48
- EPS (TTM)
- $-1.55
- Shares outstanding
- 18.05M
Price and trading
- Previous close
- 0.313
- Open
- 0.31
- Day range
- 0.2891 – 0.341
- 52-week range
- 0.25 – 1.26
- 50-day moving average
- 0.3932
- 200-day moving average
- 0.6112
- Beta
- —
- Volume
- 62.77K
- Average volume
- 1.40M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 19, 2026
Additional statistics
- Market Cap
- 5.71M
- Forward Pe
- -0.53
- Eps
- -1.55
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.26
- Week52 Low
- 0.25
- Avg Volume
- 1.40M
- Shares Outstanding
- 18.05M
- Ma50
- 0.39
- Ma200
- 0.61
- Earnings Date
- Nov 19, 2026
- Pct From52w High
- -74.90%
- Pct From52w Low
- 26.48%